Technology

{➢ XTEND ® -MP • Introduction ▪ Our modified liposomes have shown great success for systemic drug delivery by coating them by well-designed polymers which can prevent rapid uptake by the mon...

➢ LipoHANCE ®-LSE • Introduction ▪ Liposomal surface modified technology developed by Nanotriton Nord using advanced laurate sugar esters matrix, to provide advanced formula for intestinal l...

➢ LIPOCORE ® -CG • Introduction ▪ In this new technology we use an advanced formulation of liposomes, with collagen to make an advanced liposomes with more stability and less permeability. T...

➢ LIPOCELL-Hybrid ® TPGS micelles • Introduction ▪ A novel liposome-micelle-hybrid (LMH) carrier system was developed, as a superior oral drug delivery platform compared to conventional lipo...

➢ CycloMAX ® • Introduction ▪ The cyclodextrin-complex liposomes were developed as a drug carrier because it needs more time for inclusion complexes to transport from inner aqueous phase to...

➢ LipoDrone ® -BS for Liver HAPATOSOME® -BG1A • Introduction ▪ LipoDrone-BS ® for Liver is a first order target organ delivery system, to target the liver using Bile salts. These Bile s...

 ➢ LIPOCURE® -RGD-G1A • Introduction ▪ RGD modified liposomal system is a superior system for targeting cancer cells. As The arginine-glycine-aspartic acid (RGD) motif in peptide sequen...

 LipoHANCE ®- CD

{IntroductionHAPATOSOME LipoDRONE ® is a second order targeting system, which is designed for targeting Hepatic stellate cells (HSCs). HSCs involved in the progression of liver fibrosis whereas α...